日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Recurrent Resistance Mutations to Lirafugratinib Inform Treatment Sequencing in FGFR2-Driven Tumors.

对利拉夫格拉替尼的复发性耐药突变可指导 FGFR2 驱动肿瘤的治疗顺序。

Facchinetti Francesco, Hollebecque Antoine, Barbé Rémy, Jang Dong Man, Alonso-De-Castro Beatriz, Brayé Floriane, Bigot Ludovic, Nobre Catline, Da Silva Alice, Méteau Mélissandre, Delavigne Mathis, Soares Miguel, Italiano Antoine, Rodriguez Julieta, Mosele Fernanda, Beshiri Kristi, Ducreux Michel, Boilève Alice, Nikolaev Sergey, Alonso-Garcia Inmaculada, Vasseur Damien, Smolenschi Cristina, Bourien Héloise, Cotteret Sophie, Samaniego Juliette, Bernard Elsa, Nicotra Claudio, Ngo-Camus Maud, Nakazawa Seshiru, Tselikas Lambros, Badoual Cécile, André Fabrice, Eck Michael J, Olaussen Ken A, Loriot Yohann, Friboulet Luc

Ectopic Cervical Thymoma with Myasthenia Gravis and Pure Red Cell Aplasia: A Case Report

异位宫颈胸腺瘤合并重症肌无力和纯红细胞再生障碍性贫血:病例报告

Narusawa, Eiji; Obayashi, Kai; Obayashi, Sayaka; Nagashima, Toshiteru; Kawatani, Natsuko; Yazawa, Tomohiro; Yoshikawa, Ryohei; Matsumura, Nozomi; Shirabe, Ken; Nakazawa, Seshiru

Non-mucinous, enteric-type thymic adenocarcinoma: genetic analysis of a case

非黏液性肠型胸腺腺癌:一例病例的基因分析

Narusawa, Eiji; Ohtaki, Yoichi; Ishii, Genichiro; Nakazawa, Seshiru; Kawatani, Natsuko; Yazawa, Tomohiro; Numajiri, Kazuki; Yoshida, Yuka; Nimura, Keisuke; Shirabe, Ken

Completion lobectomy following segmentectomy for malignant lung tumors: a multi-institutional study of surgical feasibility, oncologic outcomes, and diagnostic challenges (ESSG-02 study)

恶性肺肿瘤肺段切除术后行肺叶切除术:一项关于手术可行性、肿瘤学结果和诊断挑战的多中心研究(ESSG-02 研究)

Watanabe, Takuya; Fujino, Kosuke; Sakane, Tadashi; Handa, Yoshinori; Doi, Takefumi; Kawatani, Natsuko; Nakazawa, Seshiru; Iida, Takahiro; Hanawa, Ryutaro; Shinohara, Shuichi; Ito, Atsushi; Tanahashi, Masayuki

A Rare Case of Sarcomatoid-Type Localized Pleural Mesothelioma Derived From Visceral Pleura

一例罕见的源自脏层胸膜的肉瘤样局限性胸膜间皮瘤

Kosaka, Takayuki; Nakazawa, Seshiru; Ushikubo, Rikuo; Ibe, Takashi; Shirabe, Ken

Activating Point Mutations in the MET Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET Inhibitors

MET激酶结构域中的激活点突变代表了肺癌和其他恶性肿瘤的一个独特的分子亚群,这些亚群可作为MET抑制剂的靶点。

Federica Pecci #,Seshiru Nakazawa #,Biagio Ricciuti,Guilherme Harada,Jessica K Lee,Joao V Alessi,Adriana Barrichello,Victor R Vaz,Giuseppe Lamberti,Alessandro Di Federico,Malini M Gandhi,Dimitris Gazgalis,William W Feng,Jie Jiang,Simon Baldacci,Marie-Anaïs Locquet,Felix H Gottlieb,Monica F Chen,Elinton Lee,Danielle Haradon,Anna Smokovich,Emma Voligny,Tom Nguyen,Vikas K Goel,Zachary Zimmerman,Sumandeep Atwal,Xinan Wang,Magda Bahcall,Rebecca S Heist,Sumaiya Iqbal,Nishant Gandhi,Andrew Elliott,Ari M Vanderwalde,Patrick C Ma,Balazs Halmos,Stephen V Liu,Jianwei Che,Alexa B Schrock,Alexander Drilon,Pasi A Jänne #,Mark M Awad #

RNF31 promotes proliferation and invasion of hepatocellular carcinoma via nuclear factor kappaB activation

RNF31通过核因子κB激活促进肝细胞癌的增殖和侵袭

Kouki Hoshino, Seshiru Nakazawa, Takehiko Yokobori, Kei Hagiwara, Norihiro Ishii, Mariko Tsukagoshi, Takamichi Igarashi, Kenichiro Araki, Norifumi Harimoto, Fuminori Tokunaga, Ken Shirabe

Prognosis of non-small cell lung cancer with postoperative regional lymph node recurrence

非小细胞肺癌术后区域淋巴结复发的预后

Ohtaki, Yoichi; Nagashima, Toshiteru; Okano, Naoko; Kubo, Nobuteru; Ohtaka, Takeru; Sunaga, Noriaki; Sakurai, Reiko; Miura, Yosuke; Nakazawa, Seshiru; Kawatani, Natsuko; Yazawa, Tomohiro; Yoshikawa, Ryohei; Narusawa, Eiji; Shirabe, Ken

The oncogenic role of LGR6 overexpression induced by aberrant Wnt/β-catenin signaling in lung cancer

肺癌中异常 Wnt/β-catenin 信号诱导的 LGR6 过表达的致癌作用

Noriaki Sunaga, Kyoichi Kaira, Kimihiro Shimizu, Ichidai Tanaka, Yosuke Miura, Seshiru Nakazawa, Yoichi Ohtaki, Reika Kawabata-Iwakawa, Mitsuo Sato, Luc Girard, John D Minna, Takeshi Hisada

Who are the real candidates for wedge resection of lung cancer?

哪些患者真正适合接受肺癌楔形切除术?

Kosaka, Takayuki; Nakazawa, Seshiru; Ibe, Takashi; Shirabe, Ken